McKesson Corporation $MCK Shares Acquired by Sanctuary Advisors LLC

Sanctuary Advisors LLC grew its position in McKesson Corporation (NYSE:MCK) by 2.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,592 shares of the company’s stock after acquiring an additional 781 shares during the quarter. Sanctuary Advisors LLC’s holdings in McKesson were worth $28,376,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Brighton Jones LLC lifted its holdings in shares of McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after purchasing an additional 798 shares during the period. Caxton Associates LLP acquired a new stake in shares of McKesson during the first quarter worth $233,000. Sivia Capital Partners LLC lifted its holdings in shares of McKesson by 77.9% during the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after purchasing an additional 300 shares during the period. Treasurer of the State of North Carolina lifted its holdings in shares of McKesson by 0.9% during the second quarter. Treasurer of the State of North Carolina now owns 58,623 shares of the company’s stock worth $42,958,000 after purchasing an additional 508 shares during the period. Finally, Osterweis Capital Management Inc. acquired a new stake in shares of McKesson during the second quarter worth $166,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at McKesson

In other news, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the transaction, the executive vice president owned 3,247 shares in the company, valued at $3,214,530. This trade represents a 45.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the transaction, the executive vice president owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. This represents a 5.98% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 3,592 shares of company stock worth $3,518,555. Corporate insiders own 0.08% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently weighed in on MCK. UBS Group decreased their price target on McKesson from $1,012.00 to $1,000.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Mizuho increased their price target on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Wall Street Zen downgraded McKesson from a “buy” rating to a “hold” rating in a report on Saturday, April 11th. Wells Fargo & Company increased their price target on McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Finally, Leerink Partners reaffirmed an “outperform” rating and set a $1,085.00 price target on shares of McKesson in a report on Thursday, March 5th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $972.27.

McKesson Stock Up 0.0%

Shares of MCK stock opened at $828.27 on Monday. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00. The stock has a market cap of $101.45 billion, a P/E ratio of 23.82, a P/E/G ratio of 1.19 and a beta of 0.42. The business has a fifty day simple moving average of $904.11 and a 200-day simple moving average of $858.73.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter last year, the business posted $8.03 earnings per share. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts anticipate that McKesson Corporation will post 39.02 earnings per share for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be given a $0.82 dividend. The ex-dividend date is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.